The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 191K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hildt, E.
Right arrow Articles by Oess, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hildt, E.
Right arrow Articles by Oess, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1999/6/1707/ $5.00
The Journal of Experimental Medicine, Volume 189, Number 11, June 7, 1999 1707-1714


Articles

Identification of Grb2 As a Novel Binding Partner of Tumor Necrosis Factor (TNF) Receptor I

Eberhard Hildt and Stefanie Oess

From the Klinikum der Universität Ulm, Ulm, 89081 Germany; and the Institut für Experimentelle Onkologie und Therapieforschung der Technischen Universität München, 81675 München, Germany

Tumor necrosis factor {alpha} (TNF-{alpha}) is a proinflammatory cytokine. Its pleiotropic biological properties are signaled through two distinct cell surface receptors: the TNF receptor type I (TNFR-I) and the TNF receptor type II. Neither of the two receptors possesses tyrosine kinase activity. A large majority of TNF-{alpha}–dependent activities can be mediated by TNFR-I. Recently, c-Raf-1 kinase was identified as an intracellular target of a signal transduction cascade initiated by binding of TNF-{alpha} to TNFR-I. However, the mechanism engaged in TNF-{alpha}–dependent activation of c-Raf-1 kinase is still enigmatic.

Here we report that the cytosolic adapter protein Grb2 is a novel binding partner of TNFR-I. Grb2 binds with its COOH-terminal SH3 domain to a PLAP motif within TNFR-I and with its NH2-terminal SH3 domain to SOS (son of sevenless). A PLAP deletion mutant of TNFR-I fails to bind Grb2. The TNFR-I/Grb2 interaction is essential for the TNF-{alpha}–dependent activation of c-Raf-1 kinase; activation of c-Raf-1 kinase by TNF-{alpha} can be blocked by coexpression of Grb2 mutants harboring inactivating point mutations in the NH2- or COOH-terminal SH3 domain, cell-permeable peptides that disrupt the Grb2/TNFR-I interaction or transdominant negative Ras. Functionality of the TNFR-I/Grb2/SOS/Ras interaction is a prerequisite but not sufficient for TNF-{alpha}–dependent activation of c-Raf-1 kinase. Inhibition of the TNFR-I/FAN (factor associated with neutral sphingomyelinase) interaction, which is essential for TNF-{alpha}–dependent activation of the neutral sphingomyelinase, either by cell-permeable peptides or by deletion of the FAN binding domain, prevents activation of c-Raf-1 kinase. In conclusion, binding of the Grb2 adapter protein via its COOH-terminal SH3 domain to the nontyrosine kinase receptor TNFR-I results in activation of a signaling cascade known so far to be initiated, in the case of the tyrosine kinase receptors, by binding of the SH2 domain of Grb2 to phosphotyrosine.

Key Words: Grb2 • tumor necrosis factor • signal transduction • cell-permeable peptides • yeast two-hybrid system


Address correspondence to Eberhard Hildt, TU München, Klinikum rechts der Isar Institut für Experimentelle Onkologie und Therapieforschung, Ismaninger Str. 22, 81675 München, Germany. Phone: 49-89-4140-4463/70; Fax: 49-89-4140-4476; E-mail: tbi12bb{at}mail.lrz-muenchen.de

Abbreviations used: aa, amino acid; AP-1, activator protein 1; CAP, ceramide-activated protein; CAT, chloramphenicol acetyltransferase; EGF, epidermal growth factor; n, neutral; NTA, nitrilotriacetic acid; Smase, sphingomyelinase; SOS, son of sevenless.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS